Skip to content

Clinical trials

Phase 1/2 trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Country / region: United States Clear all

8,214 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200086
200199
2002119
2003145
2004166
2005200
2006249
2007262
2008270
2009291
2010311
2011290
2012284
2013302
2014308
2015346
2016322
2017380
2018388
2019406
2020374
2021450
2022416
2023398
2024358
2025367
2026386

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4,030
Terminated1,386
Recruiting1,213
Active, not recruiting673
Unknown status341
Withdrawn335
Not yet recruiting136
Suspended66
Enrolling by invitation34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)306
M.D. Anderson Cancer Center264
National Institute of Allergy and Infectious Diseases (NIAID)129
Memorial Sloan Kettering Cancer Center114
Mayo Clinic97
Bristol-Myers Squibb88
Fred Hutchinson Cancer Center76
Novartis Pharmaceuticals75
Washington University School of Medicine74
Massachusetts General Hospital63

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung459
Breast Neoplasms398
Neoplasms363
Leukemia, Myeloid, Acute300
Multiple Myeloma288
Melanoma279
Neoplasm Metastasis262
Colorectal Neoplasms257
Prostatic Neoplasms257
Recurrence219

Trials

Showing 51 to 75 of 8,214. Each trial links to its page on Pharma Observatory.

8,114 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.